(UroToday.com) Following two presentations examining long-term outcomes for patients with testicular cancer in the Prostate, Testicular, and Penile Oral Abstract session at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Daneshmand summarized these data and considered both the good and bad that has accompanied the progress made in testis cancer over the past decades.